Home/Filings/4/0001104659-24-034100
4//SEC Filing

Ashman Philip 4

Accession 0001104659-24-034100

CIK 0001267602other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 9:20 PM ET

Size

8.9 KB

Accession

0001104659-24-034100

Insider Transaction Report

Form 4
Period: 2024-03-11
Ashman Philip
SVP, EU Managing Director
Transactions
  • Award

    Restricted Stock Units

    2024-03-11+6,8006,800 total
    Common Stock (6,800 underlying)
  • Award

    Performance-Based Restricted Stock Units

    2024-03-11+75,00075,000 total
    Common Stock (75,000 underlying)
Footnotes (4)
  • [F1]Each Restricted Stock Unit (RSU) represents a contingent right to receive one (1) share of the common stock of the Issuer.
  • [F2]Each Performance-Based Restricted Stock Unit (PSU) represents a contingent right to receive one (1) share of the common stock of the Issuer, subject to the achievement of applicable performance criteria.
  • [F3]The RSUs were awarded to the Reporting Person under the Alimera Sciences, Inc. 2023 Equity Incentive Plan. 25% of the RSUs are scheduled to vest on the first anniversary of the Reporting Person's vesting start date of May 20, 2024 and the remaining portion of the RSUs will vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous employment with the Issuer on each such vesting date.
  • [F4]The PSUs were awarded to the Reporting Person under the Alimera Sciences, Inc. 2023 Equity Incentive Plan. Each PSU represents the right to receive, following vesting, one (1) share of common stock of the Issuer. 1/3 of the PSUs will vest for each performance year during the 3-year performance period beginning January 2, 2024 and ending on December 31, 2026 if either one of the pre-established annual revenue target and stock price target is satisfied during such performance year, as set forth in the Reporting Person's award agreement. The number of PSUs reported reflects the maximum number of PSUs that the Reporting Person may earn at the end of the 3-year performance period.

Issuer

ALIMERA SCIENCES INC

CIK 0001267602

Entity typeother

Related Parties

1
  • filerCIK 0001564990

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 9:20 PM ET
Size
8.9 KB